Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
Evie Kozlowski is recorded as Analyst at Goldman Sachs. Evie Kozlowski has spoken on 5 earnings calls and 4 other investor events across 7 companies, most recently for Sotera Health Co on November 3, 2026. Those appearances were for Sotera Health Co (SHC), Caris Life Sciences, Inc. (CAI), Danaher Corp (DHR), Thermo Fisher Scientific Inc. (TMO), Agilent Technologies, Inc. (A) and 2 other companies. The companies whose calls Evie Kozlowski spoke on are classified in the Healthcare sector.
“And then on the 4Q guide for sterogenics, understand the med device comments.”
“So within life sciences, maybe walk through the key end markets of where we are in the recovery within academic and then biotech, but maybe specifically within emerging biotech, and then also within industrial and semis.”
“So I wanted to touch on the accelerator drug development strategy, given the strength this quarter.”
“So I wanted to touch on Agilent CrossLab. You've obviously had several quarters of really impressive instrument growth. So how should we think about the lag time between when the instrument is placed and then when you would actually expect to see the service contract booked related to that placement.”
“So I wanted to follow up on something you said in the answer to Mike's question. I think you mentioned looking at additional sequencing suppliers. Can you maybe walk us through how that could potentially change economics of each test kind of in the long term?”
Goldman Sachs
Analyst
Transcript header (unverified)
SHC
Diagnostics & Research · Healthcare
DHR
Diagnostics & Research · Healthcare
RVTY
Diagnostics & Research · Healthcare
TEM
Health Information Services · Healthcare
